Tumor-primed human natural killer cells lyse NK-resistant tumor targets: Evidence of a two-stage process in resting NK cell activation

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 85-94

  North, Janet ^a   Bakhsh, Ismail ^a   Marden, Chloe ^a   Pittman, Hanna ^a   Addison, Elena ^a   Navarrete, Cristina ^b   Anderson, Robert ^a   Lowdell, Mark W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; FLUOROCHROME; INTERLEUKIN 2;

ARTICLE; CELL ACTIVATION; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; CYTOLYSIS; HEMATOPOIETIC CELL; HLA SYSTEM; HUMAN; HUMAN CELL; LEUKEMIA CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR CELL DESTRUCTION;

EID: 33845944538     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.85     Document Type: Article

References (23)

1. Bakker, A. B., J. Wu, J. H. Phillips, and L. L. Lanier. 2000. NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals. Hum. Immunol. 61: 18-27.
2. Moretta, A., R. Biassoni, C. Bottino, M. C. Mingari, and L. Moretta. 2000. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol. Today 21: 228-234.
3. Ciccone, E., D. Pende, O. Viale, A. Than, C. Di Donato, A. M. Orengo, R. Biassoni, S. Verdiani, A. Amoroso, A. Moretta, and L. Moretta. 1992. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J. Exp. Med. 176: 963-971.
4. Gehrmann, M., H. Schmelzer, G. Eissner, T. Haferlach, W. Hiddemann, and G. Multhoff. 2003. Membrane-bound heat shock protein 70 (HSP70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica 88: 474-476.
5. Bryceson, Y. T., M. E. March, H.-G. Ljunggren, and E. O. Long. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine release. Blood 107: 159-166.
6. Testi, R., D. D'Ambrosio, R. De Maria, and A. Santoni. 1994. The CD69 receptor: a multipurpose cell surface trigger for hematopoietic cells. Immunol. Today 15: 479-483.
7. Lowdell, M. W., R. Craston, D. Samuel, M. E. Wood, E. O'Neill, V. Saha, and H. G. Prentice. 2002. Evidence that continued remission in patients treated for acute leukemia is dependent upon autologous natural killer cells. Br. J. Haematol. 117: 821-827.
8. Lopez-Cabrera, M., A. G. Santis, E. Femandez-Ruiz, R. Blacher, F. Esch, P. Sanchez-Mateos, and F. Sanchez-Madrid. 1993. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178: 537-547.
9. Brown, M. H., K. Boles, P. Anton van der Merwe, V. Kumar, A. M. Porunelloor, and A. N. Barclay. 1988. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188: 2083-2090.
10. Frohn, C., P. Schlenke, and H. Kirchner. 1997. The repertoire of HLA-Cw-specific NK cell receptors CD158a/b (EB6 and GL183) in individuals with different HLA phenotypes. Immunology 92: 567-570.
11. Whiteway, A., T. Corbett, R. Anderson, I. Macdonald, and H. G. Prentice. 2003. Expression of co-stimulatory molecules on acute myeloid leukemia blasts may effect duration of first remission. Br. J. Haematol. 120: 442-451.
12. Ruggeri, L., M. Capani, E. Urbani, K. Perrucio, W. D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, et al. 2002. Effectiveness of donor natural killer cell alloreactivity in HLA mismatched hematopoietic transplants. Science 295: 2097-2100.
13. Addison, E. G., J. North, I. Bakhsh, C. Marden, S. Haq, S. Al-Sarraj, R. Malayeri, R. G. Wickremasinghe, J. K. Davies, and M. W. Lowdell. 2005. Ligation of CD8α on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology 116: 354-361.
14. Demanet, C., A. Mulder, V. Deneys, M. J. Worsham, P. Maes, F. Claas, and S. Ferone. 2004. Down-regulation of HLA-A and Bw6, but not Bw4, allelospecificities in leukemic cells: an escape mechanism from CTL and NK attack? Blood 103: 3122-3130.
15. Nowbakht, P., M.-C. S. Ionescu, A. Rohner, C. P. Kalberer, E. Rossy, L. Moori, D. Cosman, G. De Libero, and A. Wodnar-Filipowicz. 2005. Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias. Blood 105: 3615-3622.
16. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A. M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor αβ. J. Exp. Med. 174: 1393-1398.
17. Esplugues, E., D. Sancho, J. Vega-Ramos, C. Martinez, U. Syrbe, A. Hamann, P. Engel, F. Sanchez-Madrid, and P. Lauzurica. 2003. Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 197: 1093-1106.
18. Esplugues, E., J. Vega-Ramos, D. Cartoixa, B. N. Vazquez, I. Salaet, P. Engel, and P. Lauzurica. 2005. Induction of tumor NK-cell immunity by anti-CD69 antibody therapy. Blood 105: 4399-4406.
19. von Strandmann, E. P., H. P. Hansen, K. S. Reiners, R. Schnell, P. Borchmann, S. Merkert, V. R. Simhadri, A. Draube, M. Reiser, I. Purr, et al. 2006. A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer cells and CD138 activate NK cells and has potent antitumor activity against multiple myeloma in vitro and in vivo. Blood 107: 1955-1962.
20. Pisegna, S., A. Zingoni, G. Pirozzi, B. Cinque, M. G. Cifone, S. Morrone, M. Piccoli, L. Frati, G. Palmieri, and A. Santoni. 2002. Src-dependent Syk activation controls CD69-mediated signalling and function on human NK cells. J. Immunol. 169: 68-74.
21. - cells are responsible for natural cytotoxicity against tumor targets. Leukemia 19: 835-840.
22. Wilkinson, R. W., A. E. Lee-MacAry, D. Davies, D. Snary, and E. L. Ross. 2001. Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores. J. Immunol. Methods 258: 183-191.
23. Lowdell, M. W., N. Ray, R. Craston, T. Corbett, M. Deane, and H. G. Prentice. 1997. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Bone Marrow Transplant. 19: 891-897.